TELOMIR-1, is being developed as the first novel small molecule, to lengthen the DNA’s protective telomere caps in order to affect age reversal.
Unregulated metal induced enzymatic activity
Too much of a good thing
Regulating Enzymatic activity
A novel treatment that uniquely and selectively binds critical metals to interrupt enzyme function, returning cellular metals like Iron, copper and zinc to homeostasis, and turning off the underlying cause of cancer development and growth.
By targeting specific classes of enzymes through its metal binding properties, Telomir 1 is believed to selectively affect the key processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.